Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 140

1.

Increase of complement fragment C5a in cerebrospinal fluid during exacerbation of neuromyelitis optica.

Kuroda H, Fujihara K, Takano R, Takai Y, Takahashi T, Misu T, Nakashima I, Sato S, Itoyama Y, Aoki M.

J Neuroimmunol. 2013 Jan 15;254(1-2):178-82. doi: 10.1016/j.jneuroim.2012.09.002. Epub 2012 Sep 25.

PMID:
23017732
2.

Increased soluble C5b-9 in CSF of neuromyelitis optica.

Wang H, Wang K, Wang C, Qiu W, Lu Z, Hu X.

Scand J Immunol. 2014 Feb;79(2):127-30. doi: 10.1111/sji.12132.

3.

CSF high-mobility group box 1 is associated with intrathecal inflammation and astrocytic damage in neuromyelitis optica.

Uzawa A, Mori M, Masuda S, Muto M, Kuwabara S.

J Neurol Neurosurg Psychiatry. 2013 May;84(5):517-22. doi: 10.1136/jnnp-2012-304039. Epub 2012 Dec 19.

PMID:
23255728
4.

Cerebrospinal fluid levels of iodothyronines and nerve growth factor in patients with multiple sclerosis and neuromyelitis optica.

Jiang Y, Yang Y, Zhang B, Peng F, Bao J, Hu X.

Neuro Endocrinol Lett. 2009 Mar;30(1):85-90.

PMID:
19300400
5.

Astrocytic damage is far more severe than demyelination in NMO: a clinical CSF biomarker study.

Takano R, Misu T, Takahashi T, Sato S, Fujihara K, Itoyama Y.

Neurology. 2010 Jul 20;75(3):208-16. doi: 10.1212/WNL.0b013e3181e2414b.

PMID:
20644148
6.

Cerebrospinal fluid IL-21 levels in Neuromyelitis Optica and multiple sclerosis.

Wu A, Zhong X, Wang H, Xu W, Cheng C, Dai Y, Bao J, Qiu W, Lu Z, Hu X.

Can J Neurol Sci. 2012 Nov;39(6):813-20.

PMID:
23041403
7.

Increased levels of CSF CD59 in neuromyelitis optica and multiple sclerosis.

Uzawa A, Mori M, Uchida T, Masuda H, Ohtani R, Kuwabara S.

Clin Chim Acta. 2016 Jan 30;453:131-3. doi: 10.1016/j.cca.2015.12.013. Epub 2015 Dec 11.

PMID:
26686775
8.

Cerebrospinal fluid α-synuclein levels are elevated in multiple sclerosis and neuromyelitis optica patients during replase.

Wang H, Wang K, Xu W, Wang C, Qiu W, Zhong X, Dai Y, Wu A, Hu X.

J Neurochem. 2012 Jul;122(1):19-23. doi: 10.1111/j.1471-4159.2012.07749.x. Epub 2012 Apr 19.

9.

Impaired regulatory function and enhanced intrathecal activation of B cells in neuromyelitis optica: distinct from multiple sclerosis.

Quan C, Yu H, Qiao J, Xiao B, Zhao G, Wu Z, Li Z, Lu C.

Mult Scler. 2013 Mar;19(3):289-98. doi: 10.1177/1352458512454771. Epub 2012 Aug 3.

PMID:
22864301
10.

Cerebrospinal fluid BAFF and APRIL levels in neuromyelitis optica and multiple sclerosis patients during relapse.

Wang H, Wang K, Zhong X, Qiu W, Dai Y, Wu A, Hu X.

J Clin Immunol. 2012 Oct;32(5):1007-11. doi: 10.1007/s10875-012-9709-9. Epub 2012 May 30.

PMID:
22644841
11.

Proteomic analysis of the cerebrospinal fluid in multiple sclerosis and neuromyelitis optica patients.

Jiang S, Wu J, Yang Y, Liu J, Ding Y, Ding M.

Mol Med Rep. 2012 Nov;6(5):1081-6. doi: 10.3892/mmr.2012.1025. Epub 2012 Aug 8.

PMID:
22895575
12.

Brain abnormalities in neuromyelitis optica.

Kim JE, Kim SM, Ahn SW, Lim BC, Chae JH, Hong YH, Park KS, Sung JJ, Lee KW.

J Neurol Sci. 2011 Mar 15;302(1-2):43-8. doi: 10.1016/j.jns.2010.12.001. Epub 2011 Jan 13.

PMID:
21236446
13.

Reappraisal of brain MRI features in patients with multiple sclerosis and neuromyelitis optica according to anti-aquaporin-4 antibody status.

Matsushita T, Isobe N, Piao H, Matsuoka T, Ishizu T, Doi H, Masaki K, Yoshiura T, Yamasaki R, Ohyagi Y, Kira J.

J Neurol Sci. 2010 Apr 15;291(1-2):37-43. doi: 10.1016/j.jns.2010.01.009. Epub 2010 Feb 1.

PMID:
20122699
14.

Analyses of haptoglobin level in the cerebrospinal fluid and serum of patients with neuromyelitis optica and multiple sclerosis.

Chang KH, Tseng MY, Ro LS, Lyu RK, Tai YH, Chang HS, Wu YR, Huang CC, Hsu WC, Kuo HC, Chu CC, Chen CM.

Clin Chim Acta. 2013 Feb 18;417:26-30. doi: 10.1016/j.cca.2012.12.008. Epub 2012 Dec 21.

PMID:
23262373
15.

Cerebrospinal fluid findings in aquaporin-4 antibody positive neuromyelitis optica: results from 211 lumbar punctures.

Jarius S, Paul F, Franciotta D, Ruprecht K, Ringelstein M, Bergamaschi R, Rommer P, Kleiter I, Stich O, Reuss R, Rauer S, Zettl UK, Wandinger KP, Melms A, Aktas O, Kristoferitsch W, Wildemann B.

J Neurol Sci. 2011 Jul 15;306(1-2):82-90. doi: 10.1016/j.jns.2011.03.038. Epub 2011 May 6.

PMID:
21550068
16.

Cerebrospinal fluid levels of CXCL13 are elevated in neuromyelitis optica.

Zhong X, Wang H, Dai Y, Wu A, Bao J, Xu W, Cheng C, Lu Z, Qiu W, Hu X.

J Neuroimmunol. 2011 Dec 15;240-241:104-8. doi: 10.1016/j.jneuroim.2011.10.001. Epub 2011 Oct 28.

PMID:
22036953
17.

Notable increased cerebrospinal fluid levels of soluble interleukin-6 receptors in neuromyelitis optica.

Wang H, Wang K, Zhong X, Dai Y, Qiu W, Wu A, Hu X.

Neuroimmunomodulation. 2012;19(5):304-8. doi: 10.1159/000339302. Epub 2012 Jul 6.

PMID:
22777162
18.

Comparative brain stem lesions on MRI of acute disseminated encephalomyelitis, neuromyelitis optica, and multiple sclerosis.

Lu Z, Zhang B, Qiu W, Kang Z, Shen L, Long Y, Huang J, Hu X.

PLoS One. 2011;6(8):e22766. doi: 10.1371/journal.pone.0022766. Epub 2011 Aug 10.

19.

Characteristic cerebrospinal fluid cytokine/chemokine profiles in neuromyelitis optica, relapsing remitting or primary progressive multiple sclerosis.

Matsushita T, Tateishi T, Isobe N, Yonekawa T, Yamasaki R, Matsuse D, Murai H, Kira J.

PLoS One. 2013 Apr 18;8(4):e61835. doi: 10.1371/journal.pone.0061835. Print 2013.

20.

Comparison of deep gray matter lesions on magnetic resonance imaging among adults with acute disseminated encephalomyelitis, multiple sclerosis, and neuromyelitis optica.

Zhang L, Wu A, Zhang B, Chen S, Men X, Lin Y, Lu Z.

Mult Scler. 2014 Apr;20(4):418-23. doi: 10.1177/1352458513499420. Epub 2013 Jul 25.

PMID:
23886831

Supplemental Content

Support Center